Teva Pharmaceuticals To Pay $225 Million Over Cholesterol Drug Price-Fixing
Teva Pharmaceuticals, the generic drug maker, has agreed to pay $225 million over allegations of price-fixing related to its sales of a popular cholesterol-lowering drug. Under the agreement Monday with…